Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-08-19Clinical Trial Update: A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107) [Phase 1]
Phase 1 trial assessing tolterodine tartrate for overactive bladder has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Over Active Bladder Instillation Study - Botox [Phase 3]
Phase 3 study of intravesical Botox for overactive bladder was terminated with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment [Phase 4]
Phase 4 clinical study evaluating the effect of solifenacin on the Overactive Bladder Symptom Score in adults with overactive bladder; the s…
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis [Phase 3]
Phase 3 long-term follow-up study of botulinum toxin type A for overactive bladder due to spinal cord injury or multiple sclerosis completed…
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)
A pilot sleep-lab trial to observe nocturnal bladder function in subjects with Overactive bladder has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin
An observational study was conducted to estimate the frequency of dry mouth in overactive bladder patients treated with solifenacin.
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder [Phase 4]
A Phase 4 study evaluating solifenacin with percutaneous tibial nerve stimulation versus placebo for refractory overactive bladder was termi…
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Behavioral Treatment of Overactive Bladder in Men [Phase 3]
Phase 3 clinical trial update reporting results for behavioral treatment of overactive bladder in men; results were posted after study compl…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Botulin-A Toxin Instillations and Overactive Bladder [Phase 1, Phase 2]
A Mayo Clinic-sponsored Phase 1/2 trial evaluated botulinum toxin type A instillations for overactive bladder/detrusor overactivity; results…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder. [Phase 4]
A Phase 4 clinical trial update evaluating two doses of solifenacin succinate in women with overactive bladder has completed and posted resu…
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: Effectiveness and Safety Study of Solifenacin Succinate and Solifenacin Succinate + Estrogen to Treat OAB in Postmenopausal Women [Phase 4]
Phase 4 study assessing the effectiveness and safety of solifenacin succinate alone and with estrogen for overactive bladder in postmenopaus…
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence [Phase 2]
Phase 2 trial evaluating the safety and efficacy of AGN-214868 in adults with idiopathic overactive bladder and urinary incontinence complet…
-
CLINICAL_TRIALS trial_result · 2014-03-12Clinical Trial Update: A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder. [Phase 2]
A Phase 2 trial update comparing Tarafenacin at 0.2 mg and 0.4 mg with placebo in patients with Overactive Bladder to evaluate efficacy and …
-
CLINICAL_TRIALS trial_result · 2014-02-05Clinical Trial Update: Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate [Phase 4]
Phase 4 trial comparing Percutaneous Tibial Nerve Stimulation (PTNS) alone versus PTNS with fesoterodine fumarate for Overactive Bladder was…
-
CLINICAL_TRIALS trial_result · 2014-01-24Clinical Trial Update: Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder [Phase 3]
A Phase 3 safety and efficacy trial of botulinum toxin type A for neurogenic overactive bladder was terminated, with results posted in Janua…
-
CLINICAL_TRIALS trial_result · 2013-12-31Clinical Trial Update: Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome
A clinical trial update assessing propiverine for overactive bladder syndrome reports on its efficacy, tolerability, and impact on quality o…
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine [Phase 4]
Phase 4 trial comparing 8 mg to 4 mg fesoterodine for overactive bladder has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Treatment of Symptoms in Male Patients With Lower Urinary Tract Symptoms (LUTS) Predominant Storage Symptoms (Overactive Bladder Syndrome)
Astellas Pharma Europe has completed a clinical trial evaluating treatment for storage symptoms in men with lower urinary tract symptoms (ov…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome [Phase 3]
Phase 3 clinical trial update reports results for an implantable microstimulator intended to treat urinary urgency-frequency syndrome (overa…
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome [NA]
This entry notes a completed clinical trial investigating psychiatric predisposition factors, cardiovascular effects, and prognostic factors…
-
CLINICAL_TRIALS trial_result · 2013-09-26Clinical Trial Update: Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily [Phase 4]
Phase 4 clinical trial evaluating the efficacy of Sanctura XR (trospium chloride) for reducing overactive bladder symptoms in women refracto…
-
CLINICAL_TRIALS trial_result · 2013-09-24Clinical Trial Update: Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder [Phase 4]
Phase 4 trial update evaluating the efficacy and safety of tolterodine ER in subjects with overactive bladder; study terminated with results…
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder Participants [Phase 4]
A Phase 4 efficacy and safety study of oxybutynin chloride OROS in Korean adults with overactive bladder completed, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: Extended-Release Oxybutynin for the Treatment of Neurogenic Detrusor Overactivity [Phase 4]
This Phase 4 trial of extended-release oxybutynin for neurogenic detrusor overactivity was terminated. Results were posted in July 2013.
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Pharmacokinetic Interaction Study to Assess the Effect of Repeat Doses of Rifampin on Mirabegron (YM178) in Healthy Volunteers [Phase 1]
Phase 1 pharmacokinetic interaction study assessing the effect of repeat doses of rifampin on mirabegron (YM178) in healthy volunteers has c…